Veterinary Diagnostics Market Quietly Outshines Medical Counterpart for Another Year

Veterinary Diagnostics Market Quietly Outshines Medical Counterpart for Another Year

The past year visited the U.S. IVD market with rigid cuts in lab test reimbursements and a regulatory roll-out of the Affordable Care Act (ACA) that did little to instill industry confidence. Cost drivers in medical spending were able to only in part offset such market disturbances, and generate national IVD market growth of around 3%. Quietly outperforming its larger sister market, the U.S. veterinary diagnostics market grew by about 5% in 2013.

The fundaments of the veterinary diagnostics ma...

  • by bcarlson@marketresearch.com
  • December 19 2013


Vaccine Sales Won’t Stunt IVD Revenues

Vaccine Sales Won’t Stunt IVD Revenues

Vaccines have been successful in preventing disease but that doesn’t mean they will hurt the market for products to test for those diseases. The healthcare market research publisher says a variety of factors will boost the infectious disease IVD market, even if vaccines are developed and widely distributed. The world market for infectious disease tests is estimated at $14.5 billion in 2012 and with 5% CAGR will reach $18.3 billion in 2017, according to our latest report “The World Market for Inf...

  • by bcarlson@marketresearch.com
  • December 16 2013


Infectious Diseases Exact Staggering Toll

Infectious Diseases Exact Staggering Toll

As noted in our Infectious Disease Diagnostic Test Market report, infectious diseases take a toll on the world economy, which is why IVD products are needed to help diagnose them faster. For example, WHO’s Roll Back Malaria estimates that infectious diseases result in a direct cost of some $12 billion or 1.3% of GDP growth per year for Africa. For Nigeria alone the direct loss to the economy is estimated at $850 million. ( www.rbm.who.int ) The cost of malaria is approximately 40% of public heal...


FSMA Snags Unlikely to Impair Food Safety Diagnostics Market Growth

FSMA Snags Unlikely to Impair Food Safety Diagnostics Market Growth

The rollout of the Food Safety Modernization Act (FSMA) in the United States remains plagued by significant legislator and stakeholder opposition and the latter’s inability to submit comments to regulators. Small farms and minor food producers are critical of their requirement under the law to implement more extensive procedural safeguards and routine testing. Already delayed, complete implementation of the FSMA must await the conclusion of extended comment periods (recently closed in late Novem...

  • by bcarlson@marketresearch.com
  • December 9 2013


30 Billion-Dollar Medical Tourism Market

30 Billion-Dollar Medical Tourism Market

Medical tourism will help millions of global patients find cheaper healthcare, but it is also a trend that global marketers of healthcare products should be aware of. Eight million patients across the globe cross borders to recieve treatment and pay anywhere from 3-5 thousand dollars for a variety of services, according to the group Patients Without Borders. Much of this travel represents cosmetic surgery, but more routine surgery is also included. Using their estimates, this trend represents a ...


Envisioning a Post-FFS Future for IVD

Envisioning a Post-FFS Future for IVD

In vitro diagnostic (IVD) lab technology has aided healthcare systems worldwide in directing treatment and improving public health and patient outcomes; lab technology has also played a significant role in healthcare cost escalation. Single payer systems and government health insurance systems throughout the developed world are increasingly strained by the rising costs of health services and treatments. Developing countries expanding coverage and care availability similarly have been concerned w...

  • by bcarlson@marketresearch.com
  • December 2 2013


Home Health Driving Patient Monitoring

Home Health Driving Patient Monitoring

Hospitals are under many cost constraints, which means that any product designed for hospital care alone will grow slowly. Products designed for dual purposes have a far greater chance at fast revenue growth. So it is with patient monitoring, according to Kalorama’s analysis, recently quoted in a recent article in Investor’s Business Daily. Patient monitoring in the United States should nearly double by 2017, according to Kalorma Information, and it will do so in a combination of sales to hospti...